Mayer Arie
- SEC CIK
- 0001796583
No open-market purchases or sales filed in the past year.
Current role at each company
- ORMP Oramed Pharmaceuticals Inc.Directoras of Jan 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mayer Arie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 (view filing) | Nov 1, 2021 | 190 daysLate | Mayer ArieDirector | SSale | −3.00K | $25.60 | −$76.8K | −100.0%0 after | |
| Apr 4, 2023 (view filing) | Apr 3-4 | 1 day | Mayer ArieDirector | PPurchase | +8.81K | $2.22 | +$19.5K | +48.9%26.8K after | 2 lots |